Sundance Clinical Research

What Sundance Clinical Research does

Sundance Clinical Research, LLC is a privately held, multi-specialty clinical trial site headquartered in St. Louis, Missouri, founded in 2005. The company operates a single physical facility at 711 Old Ballas Rd. that includes five exam rooms, CLIA-approved laboratories, IATA-certified staff, temperature-controlled investigational product storage (including -70°C to -20°C freezers), and dedicated monitoring rooms. It conducts Phase II through Phase IV clinical trials across gastroenterology, infectious diseases, osteoarthritis, rheumatology, cardiovascular, pain, and acute injury indications, and has completed more than 100 trials since inception. Currently active studies include COVID-19 vaccine and booster trials, influenza and RSV vaccine trials, colorectal cancer screening studies, and osteoarthritis of the knee studies.

The site is staffed by board-certified, GCP-trained physicians across multiple specialties (Family Practice, Sports Medicine, Cardiology, Emergency Medicine, Gastroenterology, OB/GYN, Pediatrics), supported by dedicated clinical research coordinators, QA, regulatory, and patient recruitment personnel. Patient recruitment leverages an internal research database, physician referral network, community outreach, paid online advertising, and organic social channels (Facebook, Instagram). Sundance's value proposition to sponsors centers on expedited study start-up with day-one enrollment readiness, multi-specialty investigator coverage, and a regulatory-grade physical infrastructure that meets CLIA, IATA, GCP, and HIPAA requirements.

Commercially, Sundance operates as a contracted research site that executes Phase II-IV trials on behalf of pharmaceutical companies and contract research organizations (CROs) under negotiated per-study fees; specific pricing is not publicly disclosed. The go-to-market motion is direct, sales-led B2B outreach to sponsors and CROs, complemented by direct-to-patient recruitment for trial enrollment. As a privately held LLC with 11-50 employees and no disclosed external funding, Sundance operates as an independent, founder/owner-operated site within a single Midwestern metro, with no evidence of multi-site expansion or institutional investment.

Name

Sundance Clinical Research

Legal name

Sundance Clinical Research, LLC

Website

https://sundanceclinicalresearch.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Sundance Clinical Research is a privately held, multi-specialty Phase II-IV clinical trial site in St. Louis, founded in 2005, that conducts studies for pharmaceutical companies and CROs across vaccine, gastroenterology, cardiovascular, and chronic disease indications.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Research & Trial Central Laboratories (HLAFAMAL), Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial services
• Phase II-IV research
• Contract research organization
• Patient recruitment services
• Clinical research facility

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services for Sponsors: Sundance provides clinical research services to pharmaceutical companies and CROs, conducting Phase II-IV trials in exchange for contracted research fees. Services include patient enrollment, data collection, regulatory compliance, and study execution.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Sundance Clinical Research is a dedicated, multi-specialty clinical research facility that conducts Phase II-IV clinical trials for pharmaceutical companies and CROs. The company provides patient recruitment, enrollment, data collection, and regulatory-compliant trial execution across multiple therapeutic areas including gastroenterology, infectious diseases, osteoarthritis, rheumatology, cardiovascular, pain, and acute injury conditions.

Product overview

Sundance Clinical Research is a dedicated, multi-specialty clinical research organization offering Phase II-IV clinical trial services. The company's core offering is conducting clinical research studies across multiple therapeutic areas including gastroenterology, infectious diseases, osteoarthritis, rheumatology, cardiovascular, pain, and acute injury. The portfolio includes specific clinical trials for COVID vaccines/boosters, colorectal cancer screening, influenza vaccines, osteoarthritis of the knee, and RSV vaccines. Supporting services include patient recruitment and retention, a fully-equipped research facility with on-site laboratories, and access to Central IRB and Central Lab services.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase II-IV Clinical Trial Services Multi-specialty clinical research organization conducting Phase II-IV clinical research studies for pharmaceutical companies and CROs across therapeutic areas including gastroenterology, infectious diseases, osteoarthritis, rheumatology, cardiovascular, pain, and acute injury conditions.
• Patient Recruitment Services Patient recruitment and retention services using research database, physician referrals, community outreach, advertising, and social media to identify, qualify and enroll patients for clinical studies on behalf of pharmaceutical sponsors.
• Clinical Research Facility Services Facility-based clinical research services including 5 state-of-the-art exam rooms, CLIA-approved laboratories, temperature-controlled storage, centralized monitoring, and 24-hour emergency staffing for sponsors and CROs.

Quantifiable outcome

• Completed more than 100 clinical trials since 2005
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Velocity Clinical Research: Velocity operates one of the largest dedicated SMO site networks in the U.S., conducting Phase II-IV trials across multiple therapeutic areas. It is the closest direct peer to Sundance in business model (dedicated research site serving pharma/CRO sponsors with multi-specialty capabilities), differing primarily in geographic scale.
• Accel Research Sites: Accel is a multi-site SMO network running Phase II-IV trials for pharma sponsors across therapeutic areas including vaccines, gastroenterology, and women's health. Directly comparable to Sundance as a dedicated clinical research site organization serving similar sponsor customers.
• Javara Inc. Javara is an integrated SMO that embeds research operations within healthcare systems to run clinical trials. It is comparable to Sundance in offering dedicated multi-specialty site services for Phase II-IV trials with a focus on sponsor enrollment support.
• Optimal Research: Optimal Research is a privately held SMO operating multiple dedicated research sites across the U.S. for Phase II-IV trials. Comparable to Sundance as a multi-therapeutic site business targeting pharma and CRO sponsors.
• Flourish Research: Flourish Research is a multi-site SMO platform serving pharmaceutical and biotech sponsors with Phase II-IV clinical trials across diverse therapeutic areas. Comparable to Sundance as a dedicated site business with multi-specialty physician coverage.

Emerging players

• Circuit Clinical: Circuit Clinical operates an SMO platform that integrates clinical research into physician practices and community settings. Comparable to Sundance in serving sponsor customers with Phase II-IV trials, with an emerging tech-enabled twist on traditional site operations.

Broad incumbents

• IQVIA: IQVIA is the largest global CRO and operates a substantial dedicated site network as part of its broader clinical research services portfolio. It competes with Sundance for the same pharma/CRO sponsor contracts but at vastly greater scale and geographic reach.
• ICON plc: ICON is a top-3 global CRO offering full-service clinical development including site management and patient recruitment. It is comparable to Sundance as a Phase II-IV trial services provider for pharma sponsors, but operates at much broader scope.
• Medpace Holdings: Medpace is a mid-to-large CRO focused on Phase II-IV clinical development for small and mid-sized biopharma. It competes with Sundance for the same sponsor relationships and trial execution revenue, but at materially larger scale.
• WCG (WIRB-Copernicus Group): WCG provides clinical research site services including central IRB, technology, and consulting to sponsors and sites. It is adjacent to Sundance as a clinical research services provider serving the same pharma/CRO customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/sundanceclinicalresearch
• Instagraminstagram.com/sundanceclinical
• Xx.com/sundancestl

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sundance Clinical Research